Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Primary Prevention of Stroke in Children With SCD in Sub-Saharan Africa II: A Multicenter, Open-label, Single-arm Type I Hybrid Clinical Trial

NCT06526117 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.

NCT NCT06526117
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06526117 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Primary Prevention of Stroke in Children With SCD in Sub-Saharan Africa II: A Multicenter, Open-label, Single-arm Type I Hybrid Clinical Trial
Lead sponsor
Vanderbilt University Medical Center
Phase
Phase 4
Overall status
Recruiting
Start date
August 5, 2024
Completion date
June 30, 2030
Enrollment
220 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cell disease, stroke